Ivabradine tablet bulk supplier for pharma manufacturers

Ivabradine Tablet 5 mg, 7.5 mg, and 9 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 5 mg, 7.5 mg, and 9 mg

Reference Brands: Corlanor(US), Procoralan(EU)

Ivabradine selectively inhibits funny current (If) channels in the sinoatrial node, lowering heart rate without affecting blood pressure or ventricular contractility. It reduces angina attacks, improves exercise tolerance, and decreases hospitalization risk in chronic heart failure. Benefits include better heart rate control, symptom relief, and improved quality of life.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Ivabradine tablets, marketed as Corlanor (US) and Procoralan (EU), are approved for chronic stable angina and heart failure management. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality information, while the EMA ensures compliance with safety and manufacturing standards across European regions. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring regional regulatory adherence supports timely approval, safe use, and worldwide availability of ivabradine tablets, helping improve heart rate management and reduce cardiovascular events globally.

Ivabradine Tablet — third party manufacturing & bulk supply

Ivabradine Tablet 5 mg, 7.5 mg, and 9 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ivabradine Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ivabradine Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ivabradine Tablet →

Back to Listing

Frequently Asked Questions

Ivabradine tablet is listed as Tablet in 5 mg, 7.5 mg, and 9 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ivabradine tablet is referenced against Corlanor(US), Procoralan(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.